Pirenoxine sodium

Modify Date: 2024-01-04 00:18:28

Pirenoxine sodium Structure
Pirenoxine sodium structure
Common Name Pirenoxine sodium
CAS Number 51410-30-1 Molecular Weight 330.227
Density 1.7g/cm3 Boiling Point 515.8ºC at 760mmHg
Molecular Formula C16H7N2NaO5 Melting Point N/A
MSDS N/A Flash Point 265.7ºC

 Names

Name sodium,1,5-dioxo-4H-pyrido[3,2-a]phenoxazine-3-carboxylate
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.7g/cm3
Boiling Point 515.8ºC at 760mmHg
Molecular Formula C16H7N2NaO5
Molecular Weight 330.227
Flash Point 265.7ºC
Exact Mass 330.025269
PSA 116.35000
LogP 0.91010

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UV1151200
CHEMICAL NAME :
5H-Pyrido(3,2-a)phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-, monosodium salt
CAS REGISTRY NUMBER :
51410-30-1
LAST UPDATED :
199103
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C16-H7-N2-O5.Na
MOLECULAR WEIGHT :
330.24
WISWESSER LINE NOTATION :
T D6 B666 CN JO MV ONJ PVO RQ &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Behavioral - antipsychotic Liver - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 8,911,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1460 mg/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Behavioral - antipsychotic
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 8,911,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Behavioral - antipsychotic Liver - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 8,911,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Behavioral - antipsychotic Liver - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 8,911,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2120 mg/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Behavioral - antipsychotic
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 8,911,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Behavioral - antipsychotic Liver - other changes
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 8,911,1974

 Safety Information

HS Code 2934999090

 Customs

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

Pirenoxine sodium
Clarvisan (TN)
Sodium 1-hydroxy-5-oxo-5H-pyrido[3,2-a]phenoxazine-3-carboxylate
Pirenoxine sodium salt
Catalin sodium
1-Hydroxy-5-oxo-5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, monosodium salt
EINECS 257-181-6
T D6 B666 CN JO MV ONJ PVQ RQ &&Na Salt
5H-Pyrido(3,2-a)phenoxazine-3-carboxylic acid,1-hydroxy-5-oxo-,monosodium salt
1-Hydroxy-5-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylic acid sodium salt
5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-, monosodium salt
5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-, sodium salt (1:1)